Literature DB >> 21270157

Reproduction in vitro of a quasispecies from a hepatitis C virus-infected patient and determination of factors that influence selection of a dominant species.

Kazunori Kawaguchi1, Kristina Faulk, Robert H Purcell, Suzanne U Emerson.   

Abstract

Hepatitis C virus infections proceed to chronicity in the majority of cases. In patients, hepatitis C viruses exist as a dynamic and complex quasispecies. The dominant species at any one time arises in response to host immune pressure and other, incompletely understood factors. It is critical to understand all the mechanisms by which dominance is achieved, but this is difficult to study in vivo. Therefore, it would be useful to develop a cell culture system in which naturally occurring quasispecies could be studied. Hepatitis C virus glycoprotein genes E1 and E2 were PCR amplified as a cassette from the plasma of a chronically infected patient and shotgun cloned into a modified 1a/JFH1 infectious cDNA clone. Following transformation of bacteria, plasmids were batch harvested, transcribed, and transfected into Huh7.5 cells to produce a quasispecies of hypervariable region 1 (HVR1) that mimicked that circulating in vivo. Serial passage of the quasispecies in vitro resulted in replacement of the initially dominant species with a new HVR1 species coexisting with selected growth-enhancing mutations located outside HVR1. Antibody raised against one HVR1 sequence neutralized virus with the homologous HVR1 and cross-neutralized virus with a different sequence. Reciprocal swapping of the HVR1 regions between the two dominating species demonstrated that the HVR1 sequence affects the efficiency of replication and of neutralization by anti-HVR1 but that both processes are strongly influenced by regions outside HVR1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270157      PMCID: PMC3067868          DOI: 10.1128/JVI.02554-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

Review 1.  Global epidemiology and burden of hepatitis C.

Authors:  W Ray Kim
Journal:  Microbes Infect       Date:  2002-10       Impact factor: 2.700

Review 2.  Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes.

Authors:  J Bukh; R H Miller; R H Purcell
Journal:  Semin Liver Dis       Date:  1995-02       Impact factor: 6.115

3.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Authors:  Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; T Jake Liang
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

4.  Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein.

Authors:  P Farci; A Shimoda; D Wong; T Cabezon; D De Gioannis; A Strazzera; Y Shimizu; M Shapiro; H J Alter; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

5.  Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees.

Authors:  X Forns; R Thimme; S Govindarajan; S U Emerson; R H Purcell; F V Chisari; J Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

6.  A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.

Authors:  Y K Shimizu; H Igarashi; T Kiyohara; T Cabezon; P Farci; R H Purcell; H Yoshikura
Journal:  Virology       Date:  1996-09-15       Impact factor: 3.616

7.  Long PCR and its application to hepatitis viruses: amplification of hepatitis A, hepatitis B, and hepatitis C virus genomes.

Authors:  R Tellier; J Bukh; S U Emerson; R H Miller; R H Purcell
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

Review 8.  What is disrupting IFN-alpha's antiviral activity?

Authors:  M Lamine Mbow; Robert T Sarisky
Journal:  Trends Biotechnol       Date:  2004-08       Impact factor: 19.536

9.  Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein.

Authors:  Gabrielle Vieyres; Jean Dubuisson; Arvind H Patel
Journal:  J Gen Virol       Date:  2010-11-17       Impact factor: 3.891

10.  Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.

Authors:  Birke Bartosch; Jean Dubuisson; François-Loïc Cosset
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

View more
  4 in total

1.  Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection.

Authors:  Chaturaka Rodrigo; Melanie R Walker; Preston Leung; Auda A Eltahla; Jason Grebely; Gregory J Dore; Tanya Applegate; Kimberly Page; Sunita Dwivedi; Julie Bruneau; Meghan D Morris; Andrea L Cox; William Osburn; Arthur Y Kim; Janke Schinkel; Naglaa H Shoukry; Georg M Lauer; Lisa Maher; Margaret Hellard; Maria Prins; Fabio Luciani; Andrew R Lloyd; Rowena A Bull
Journal:  Infect Genet Evol       Date:  2017-01-05       Impact factor: 3.342

2.  Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion.

Authors:  Mo Guan; Wenbo Wang; Xiaoqing Liu; Yimin Tong; Yuan Liu; Hao Ren; Shiying Zhu; Jean Dubuisson; Thomas F Baumert; Yongzhe Zhu; Haoran Peng; Laure Aurelian; Ping Zhao; Zhongtian Qi
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

3.  Sequence and functional analysis of the envelope glycoproteins of hepatitis C virus variants selectively transmitted to a new host.

Authors:  Valentina D'Arienzo; Alain Moreau; Louis D'Alteroche; Valérie Gissot; Emmanuelle Blanchard; Catherine Gaudy-Graffin; Emmanuelle Roch; Frédéric Dubois; Bruno Giraudeau; Jean-Christophe Plantier; Alain Goudeau; Philippe Roingeard; Denys Brand
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

4.  Synonymous Co-Variation across the E1/E2 Gene Junction of Hepatitis C Virus Defines Virion Fitness.

Authors:  Brendan A Palmer; Liam J Fanning
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.